FRA:PFE - Deutsche Boerse Ag - US7170811035 - Common Stock - Currency: EUR
Overall PFE gets a fundamental rating of 5 out of 10. We evaluated PFE against 53 industry peers in the Pharmaceuticals industry. There are concerns on the financial health of PFE while its profitability can be described as average. PFE may be a bit undervalued, certainly considering the very reasonable score on growth
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROIC | 6.92% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Altman-Z | 2.11 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.25 | ||
Fwd PE | 7.37 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 11.78 | ||
EV/EBITDA | 6.79 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.33% |
FRA:PFE (6/2/2025, 5:21:18 PM)
20.51
-0.22 (-1.09%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.33% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.25 | ||
Fwd PE | 7.37 | ||
P/S | 2.12 | ||
P/FCF | 11.78 | ||
P/OCF | 9.45 | ||
P/B | 1.46 | ||
P/tB | N/A | ||
EV/EBITDA | 6.79 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.79% | ||
ROE | 8.73% | ||
ROCE | 9.87% | ||
ROIC | 6.92% | ||
ROICexc | 7.7% | ||
ROICexgc | 36.63% | ||
OM | 27.12% | ||
PM (TTM) | 12.62% | ||
GM | 74.57% | ||
FCFM | 17.96% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 5.54 | ||
Debt/EBITDA | 2.45 | ||
Cap/Depr | 40.16% | ||
Cap/Sales | 4.43% | ||
Interest Coverage | 5.35 | ||
Cash Conversion | 58.69% | ||
Profit Quality | 142.33% | ||
Current Ratio | 1.26 | ||
Quick Ratio | 0.96 | ||
Altman-Z | 2.11 |